Dysport® is a Botulinum Toxin Type A that is very similar to BOTOX. They are both registered in New Zealand for the treatment of facial wrinkles.
Botox® (onabotulinumtoxinA) was approved by the Food and Drug Administration (FDA) to treat frown lines — those pesky wrinkles between the eyebrows — in 2002. In 2009, a competitor, Dysport® (abobotulinumtoxinA) was approved for the same use.
Researchers from the Maas Clinic in San Francisco and University of California, San Francisco, enrolled 90 people for a “split face” study in which doctors randomly injected Botox into one side of the face and Dysport into the other. At the 30-day mark, about two-thirds of participants said they also favored the side that had been treated with Dysport."(Source: Time Magazine)
PLEASE NOTE: A freight charge of $15 applies to this product. Please add stockcode to your cart FRCOLD